EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression

Waseem Raza, Abha Meena iD, Suaib Luqman

Molecular Carcinogenesis · 2024-09 · 63 (9) · 1627-1642

DOI: 10.1002/mc.23774 ↗

At a glance

Übersichtsarbeit in Molecular Carcinogenesis, published online on 2024-06-18. Written by Waseem Raza and 2 co-authors. Institution: Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India. Major MEDLINE topics: Neoplasms, Signal Transduction, Flavonoids. Cited 27 times so far (Crossref); 104 references. Funded by: CSIR-Central Institute of Medicinal and Aromatic Plants, Central Institute of Medicinal and Aromatic Plants.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Flavonoids, constituting the most extensive category of polyphenols, founds in a variety of plants and comprise over 9000 compounds. Diosmetin, O‐methylated flavone (3’,5,7‐trihydroxy‐4’‐methoxyflavone) of flavonoid aglycone diosmin have witnessed a significant surge in recent years. Many studies showed that flavonoids induced cytotoxicity in different organ specific cancer types. Thus, current review evaluates the anticancer potential of diosmetin and shed light on its mechanism of action such as cell cycle regulation, apoptosis via both intrinsic and extrinsic pathway, autophagy and tumour progression and metastasis. It also provides comprehensive analysis of different cancer targets and their role in breast, colon, hepatic, gliomas, leukemia, lung, prostate and skin cancer. Combination studies of diosmetin to improve drug sensitivity and reduce toxicity towards normal cells has been also discussed. Besides, in vitro studies, present review also discuss the anticancer potential of diosmetin on xenograft mice model. Different natural sources of diosmetin, limitations, pharmacokinetic analysis and toxicity study also summarized in current review. The emphasis on enhancing solubility and permeability for clinical utility has been thoroughly highlighted with particular attention given to the utilization of nano formulations to overcome existing barriers. At last, in‐depth analysis of current challenges and a forward‐looking perspective deliberated to address the existing gaps and position it as a promising lead compound for clinical applications in cancer treatment. This discussion is boosted by diosmetin's potential anticancer properties on different cancers, makes valuable candidates in the ongoing quest for effective therapeutic interventions against cancer.

Subjects

MeSH terms (MEDLINE)

NeoplasmsSignal TransductionFlavonoidsHumansAnimalsDisease ProgressionFlavonesApoptosis

Author keywords

apoptosiscancercell cyclediosmetinmetastasis

Substances

diosmetinFlavonoidsFlavones

Authors and institutions

  • Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India.
  • Jawaharlal Nehru University, New Delhi, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.

ORCID profiles: Abha Meena

Funding

  • CSIR-Central Institute of Medicinal and Aromatic Plants
  • Central Institute of Medicinal and Aromatic Plants

Cite

APA

Raza, W., Meena, A., & Luqman, S. (2024). Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression. Molecular Carcinogenesis, 63(9), 1627-1642. https://doi.org/10.1002/mc.23774

Vancouver

Raza W, Meena A, Luqman S. Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression. Molecular Carcinogenesis. 2024;63(9):1627-1642. doi:10.1002/mc.23774

BibTeX
@article{Raza2024,
  author = {Raza, Waseem and Meena, Abha and Luqman, Suaib},
  title = {Diosmetin: A dietary flavone as modulator of signaling pathways in cancer progression},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  volume = {63},
  number = {9},
  pages = {1627--1642},
  doi = {10.1002/mc.23774}
}
Start for free →